U.S. Markets open in 13 hrs, 33 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,387.61 | 936.42 | 11.08% |
| NASDAQ | 1,844.25 | 194.74 | 11.81% |
| S&P 500 | 1,003.35 | 104.13 | 11.58% |
| Day Low 09:57 AM EDT | 12.29 | |
|---|---|---|
| Day High 03:32 PM EDT | 14.49 |
|
| Range | 2.20 | |
| Volume | 650,055 | |
| 30-Day Avg. Vol. | 327,000 |
|
| Difference | 98.79% | |
| Market Cap. | 244 M | |
| Change | 45.03 M | |
| Shares Out. | 17.12 M | |
| Percent Traded | 3.80% | |
| Revenue (LFY) | 61.7 M | |
| Earnings (TTM) | 11.94 M | |
| Next Earnings | 11/06/2008 |
|
| EPS (TTM) | 0.70 |
| 52-Wk Low 10/10/08 | 8.99 | |
|---|---|---|
| 52-Wk High 10/12/07 | 38.86 |
|
| Range | 29.87 | |
| Prev. Close 10/10/08 | 11.62 | |
| Today's Open | 12.99 | |
| Change | 11.79% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | — | |
| P/E Ratio (TTM) | 20.36 | |
| P/E Ratio (Fwd.) | 20.00 |
Omrix Biopharmaceuticals helps keep the operating room from becoming a bloody mess. The company develops biosealants derived from human plasma to control bleeding during surgical procedures. The biosealants ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.134 3/31/08 | 0.12 3/31/08 |
-0.014
Missed
|
| Last Quarter | 0.131 6/30/08 | 0.17 6/30/08 |
0.039
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 19.20 M | 61.70 M |
| Gross Profit | 7.57 M | 24.04 M |
| Operating Income | 2.19 M | 5.92 M |
| Net Income | 2.99 M | 11.94 M |
